Titel

Merkliste
1 Ergebnisse

Study on Efficacy and Safety of Low-Dose Apatinib Combined ..:

Wang KX ; Cui TY ; Yang XD...
https://www.dovepress.com/study-on-efficacy-and-safety-of-low-dose-apatinib-combined-with-camrel-peer-reviewed-fulltext-article-OTT. , 2021

Link: https://doaj.org/article/1920cf06adc944ccb14106092eae4..

RT Journal
T1 <Title>Study on Efficacy and Safety of Low-Dose Apatinib Combined with Camrelizumab and SOX Regimen as First-Line Treatment of Locally Advanced and Unresectable Gastric/Gastroesophageal Junction Cancer: A Protocol for an Open-Label, Dose Escalation and Extension Phase Ib Clinical Trial</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:1920cf06adc944ccb14106092eae468e&Exemplar=1&LAN=DE
				
A1 Wang KX
A1 Cui TY
A1 Yang XD
A1 Wang GQ
A1 Jiang QS
A1 Sun H
A1 Jiang NY
A1 Yong XM
A1 Shi CB
A1 Ding YB
A1 Chen XF
A1 Fang YY
PB Dove Medical Press
YR 2021
K1 clinical trial
K1 agc/gejc
K1 low-dose apatinib
K1 camrelizumab
K1 sox regimen
K1 protocol
K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens
K1 RC254-282
JF https://www.dovepress.com/study-on-efficacy-and-safety-of-low-dose-apatinib-combined-with-camrel-peer-reviewed-fulltext-article-OTT
LK http://dx.doi.org/https://doaj.org/article/1920cf06adc944ccb14106092eae468e
DO https://doaj.org/article/1920cf06adc944ccb14106092eae468e
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)